Short answer
USANA HEALTH SCIENCES INC (USNA) filed an 8-K current report with the SEC on August 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 FY2026 results released for quarter ended July 4, 2026.
USANA HEALTH SCIENCES INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 FY2026 results released for quarter ended July 4, 2026
- Management Commentary furnished as Exhibit 99.2 for financial and operating details
- Investor conference call scheduled with management remarks followed by Q&A
- Investors should review Exhibits 99.1 and 99.2 for performance figures and outlook signals
Item EX-99.1 · Exhibit EX-99.1
- Q2 net sales fell 5% to $223 million, while adjusted EBITDA attributable to USANA declined 9% to $27.8 million
- $29.1 million preliminary non-cash Hiya goodwill impairment drove a $21.4 million net loss and $(1.16) diluted EPS
- Core Nutritional sales declined 4% to $192 million, with active customers down 8% to 384,000
- Hiya sales fell 17% to $28 million and subscribers declined 17% to 166,000; Rise sales increased 40% to $3 million
- FY2026 outlook reset to $910 million sales, $(11) million net loss, and $87 million adjusted EBITDA; company remains debt-free with $169 million cash
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other USANA HEALTH SCIENCES INC 8-K filings
Get the next USNA 8-K as it lands
Follow USNA for push alerts, or ask the research agent what this filing means.